FindTrial
Sign In

Do People with Mucosal Lichen Planus Have a Higher Risk of Metabolic Syndrome?

Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/096658
Enrollment
70
Registered
2025-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L438- Other lichen planus

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Benita Edith Chelliah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: I) Patients aged 18 years and above diagnosed with mucosal lichen planus (clinically or histopathologically confirmed) 2) Healthy individuals without Lichen Planus or systemic inflammatory diseases as controls.

Exclusion criteria

Exclusion criteria: 1) Patients on systemic steroids, retinoids 2) Pregnant and lactating women 3) Patients with Autoimmune or Chronic Inflammatory conditions

Design outcomes

Primary

MeasureTime frame
To determine the prevalence of metabolic syndrome in patients with mucosal lichen planusTimepoint: End of study period—

Secondary

MeasureTime frame
To identify local factors influencing Mucosal Lichen PlanusTimepoint: End of study period—

Countries

India

Contacts

Public ContactPrathibha J P

St.Johns Medical College Hospital

prathibha.jp@stjohns.in9886695980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026